Educational attainment of individuals with lymphangioleiomyomatosis is a determinant of timely diagnosis and treatment uptake
Abstract Background Lymphangioleiomyomatosis (LAM) is a rare, progressive lung disease predominantly affecting women. Despite the availability of FDA-approved treatments, mTOR inhibitors like sirolimus or everolimus, significant disparities persist in early diagnosis, treatment utilization, and pati...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2026-02-01
|
| Edice: | Orphanet Journal of Rare Diseases |
| Témata: | |
| On-line přístup: | https://doi.org/10.1186/s13023-026-04284-8 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|